223 related articles for article (PubMed ID: 30360813)
1. Organosilica Nanoparticles and Medical Imaging.
Nakamura M
Enzymes; 2018; 44():137-173. PubMed ID: 30360813
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
4. Silica based hybrid materials for drug delivery and bioimaging.
Bagheri E; Ansari L; Abnous K; Taghdisi SM; Charbgoo F; Ramezani M; Alibolandi M
J Control Release; 2018 May; 277():57-76. PubMed ID: 29550399
[TBL] [Abstract][Full Text] [Related]
5. Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.
Chen Y; Shi J
Adv Mater; 2016 May; 28(17):3235-72. PubMed ID: 26936391
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
7. Overview of stimuli-responsive mesoporous organosilica nanocarriers for drug delivery.
Guimarães RS; Rodrigues CF; Moreira AF; Correia IJ
Pharmacol Res; 2020 May; 155():104742. PubMed ID: 32151682
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
[TBL] [Abstract][Full Text] [Related]
9. Functional mesoporous silica nanoparticles for bio-imaging applications.
Cha BG; Kim J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1515. PubMed ID: 29566308
[TBL] [Abstract][Full Text] [Related]
10. Large Pore Mesoporous Silica and Organosilica Nanoparticles for Pepstatin A Delivery in Breast Cancer Cells.
Rahmani S; Budimir J; Sejalon M; Daurat M; Aggad D; Vivès E; Raehm L; Garcia M; Lichon L; Gary-Bobo M; Durand JO; Charnay C
Molecules; 2019 Jan; 24(2):. PubMed ID: 30658511
[TBL] [Abstract][Full Text] [Related]
11. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
12. Tailoring cubic and dodecagonal quasicrystalline mesophases of mesoporous organosilica nanoparticles and core/shell structure.
Baipaywad P; Wi JS; Park H; Paik T
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():666-674. PubMed ID: 30813071
[TBL] [Abstract][Full Text] [Related]
13. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
Fadeel B; Garcia-Bennett AE
Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
[TBL] [Abstract][Full Text] [Related]
14. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
15. Silica/organosilica cross-linked block copolymer micelles: a versatile theranostic platform.
Niu D; Li Y; Shi J
Chem Soc Rev; 2017 Feb; 46(3):569-585. PubMed ID: 27805705
[TBL] [Abstract][Full Text] [Related]
16. The development of chiral nematic mesoporous materials.
Kelly JA; Giese M; Shopsowitz KE; Hamad WY; MacLachlan MJ
Acc Chem Res; 2014 Apr; 47(4):1088-96. PubMed ID: 24694253
[TBL] [Abstract][Full Text] [Related]
17. Two-Photon-Excited Silica and Organosilica Nanoparticles for Spatiotemporal Cancer Treatment.
Croissant JG; Zink JI; Raehm L; Durand JO
Adv Healthc Mater; 2018 Apr; 7(7):e1701248. PubMed ID: 29345434
[TBL] [Abstract][Full Text] [Related]
18. Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles.
Croissant JG; Fatieiev Y; Khashab NM
Adv Mater; 2017 Mar; 29(9):. PubMed ID: 28084658
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent hybrid silica nanoparticles and their biomedical applications.
Yang S; Li Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1603. PubMed ID: 31837124
[TBL] [Abstract][Full Text] [Related]
20. Periodic Mesoporous Organosilica Nanoparticles with BOC Group, towards HIFU Responsive Agents.
Li H; Gascó C; Delalande A; Charnay C; Raehm L; Midoux P; Pichon C; Pleixats R; Durand JO
Molecules; 2020 Feb; 25(4):. PubMed ID: 32098283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
